Bayer’s agricultural sciences division reported sales of 5.39 billion euros in the fourth quarter, up 0.2% from the same period last year. The result was driven by a 5.6% increase in volume and a 0.7% increase in prices, which offset the negative impact of 6.1% resulting from exchange rate variations. Year-to-date, sales totaled 21.622 billion euros, a drop of 2.9% year-on-year.
In Latin America, sales totaled 2.26 billion euros in the fourth quarter, growth of 8.2%. However, in the year to date, the region recorded a decline of 1.8%, with revenues of 6.13 billion euros.
Ebitda (earnings before interest, taxes, depreciation and amortization) was negative at R$2.586 billion in the quarter. In the same period of the previous year, Ebitda had a positive result of R$788 million. In the year to date, the indicator went from a positive R$3.96 billion in 2024 to a negative R$1.58 billion.
According to the company, the results were impacted by regulatory pressures, higher expenses related to the group’s short-term incentive program and by strategic actions, including costs associated with portfolio rationalization. The lack of revenue recorded in the previous year from the sale of non-essential businesses also contributed.
Bayer also highlighted its plan to contain litigation in the United States. The company announced, through its subsidiary Monsanto, a up to $7.25 billion proposed for a nationwide class action lawsuit in the United States aimed at resolving current and future claims, including cancer cases.
Result by segment
The performance was mainly driven by the corn seeds and genetic traits segment, which registered growth of 19.6% in sales in the quarter and 9% in the year to date, totaling 7.15 billion euros in 2025. The advance was recorded in all regions, with the impact of the increase in planted area, product performance and the resolution of a licensing agreement with Corteva in North America.
The vegetable seeds segment also showed growth, with an increase of 2.1% year-to-date, supported by increases in prices and volumes in almost all regions.
On the other hand, sales of cotton seeds fell 24.4%, with performance affected mainly in the United States by the cancellation of the company’s product registration and the reduction in planted area. The soybean seeds and genetic traits business also recorded a drop in sales. In Latin America, however, there was growth.
Insecticide sales fell 16.5%, influenced by the expiration of the registration of one of the group’s products in Europe. The herbicides segment remained at a similar level to the previous year. Non-glyphosate-based products performed positively in Latin America and the Europe/Middle East/Africa region, while glyphosate-based products saw higher prices and higher volumes in North America, offset by declines in Latin America.
Fungicide sales were below those recorded in the previous year, with a decline in North America and Asia/Pacific, attributed to market and climate factors. On the other hand, there was an increase in volumes in Europe/Middle East/Africa.
Group results
The Bayer group had a 2.5% drop in sales in the fourth quarter, totaling 11.4 billion euros. In the year to date 2025, sales fell 2.2%, totaling 45.6 billion euros.
Ebitda fell 80.4% in 2025, from 8.7 billion to 1.7 billion euros.
